VP, Clinical Care Delivery

The Problem Severe mental illness affects over 15 million adults in the United States. Schizophrenia. Schizoaffective disorder. Bipolar I. Treatment-resistant depression. These are the conditions the rest of healthcare has systematically failed to build for. What makes this problem different from most of healthcare is that the tools to solve it do not exist. The clinical protocols, the measurement science, the precision medicine, the technology to deliver coordinated longitudinal outpatient care for this population. None of it has been built. This is a frontier problem, and it requires frontier science and care delivery to solve. We are developing all of it. The care, the science, the technology. Who We Are Amae Health is a Series B, venture-backed Public Benefit Corporation that delivers specialty outpatient care for people living with severe mental illness, including schizophrenia, schizoaffective disorder, bipolar I disorder, and treatment-resistant depression. We design and operate high-acuity, in-person clinics across the United States. Our model integrates psychiatry, therapy, primary care, dietitians, and community health workers under one roof to deliver coordinated, longitudinal care for a population that has historically been fragmented across systems. Leading health systems partner with Amae to bring this model to their communities, including NewYork-Presbyterian, C...